New Hybrids Derived from the Natural Compound (-)-β-Pinene and Amides or Acylthioureas as Antitumor Agents

Author(s): Shengliang Liao, Xiaoping Rao, Minggui Shen, Hongyan Si, Jie Song, Shibin Shang*, Zhanqian Song*

Journal Name: Letters in Drug Design & Discovery

Volume 17 , Issue 3 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Plant-derived natural compounds have a unique molecular structure and rich biological activity, hence, they are treated as important raw materials for the development of drugs.

Methods: A natural compound (-)-β-pinene was used as a raw material, and twenty-six novel derivatives with amide or acylthiourea groups were synthesized based on the molecular hybridization method. In vitro antitumor activity of these derivatives on human breast cancer cell line MCF7 and human colon cancer cell line SW1116 were tested by MTT method. The effects of the synthesized derivatives on the morphology of MCF7 and SW1116 were observed by fluorescent inverted microscope.

Results: The preliminary structure-activity relationship analysis demonstrates that the position and species of substituents on the aromatic ring of derivatives have an effect on the antitumor activity of derivatives. Observation of the cell morphology reveals that derivatives with antitumor activity can lead to rounding of the cell morphology, a decrease in cell volume and cell density, and ultimately inhibition of the proliferation of MCF7 and SW1116 cells. The antitumor activity evaluation results show that among these derivatives, compounds 5c, 5e, 5h, 7c, 7b and 7e exhibit good antitumor activity against MCF7, and compounds 5c, 5e, 5h and 7j exert moderate antitumor activity against SW1116.

Conclusion: This study hopes to promote the high value-added utilization of natural compounds β-pinene and the development of novel antitumor drugs.

Keywords: Pinene, amide, acylthiourea, synthesis, antitumor, MCF7, SW1116.

[1]
Statista Number of cancer deaths worldwide in 2018, by major type of cancer, 2018. Available at: https://www.statista.com/statistics/288580/number-of-cancer-deaths-worldwide-by-type/ [Accessed date: Jul 22, 2019]
[2]
Chen, H.X.; Cleck, J.N. Adverse effects of anticancer agents that target the VEGF pathway. Nat. Rev. Clin. Oncol., 2009, 6(8), 465-477.
[http://dx.doi.org/10.1038/nrclinonc.2009.94] [PMID: 19581909]
[3]
Remesh, A. Toxicities of anticancer drugs and its management. Int. J. Basic Clin. Pharmacol., 2017, 1(1), 2-12.
[http://dx.doi.org/10.5455/2319-2003.ijbcp000812]
[4]
Kartal-Yandim, M.; Adan-Gokbulut, A.; Baran, Y. Molecular mechanisms of drug resistance and its reversal in cancer. Crit. Rev. Biotechnol., 2016, 36(4), 716-726.
[PMID: 25757878]
[5]
Manju, K.; Jat, R.; Anju, G. A review on medicinal plants used as a source of anticancer agents. Intl. J. Drug Res.Technol., 2017, 2(2), 177-183.
[6]
Zhao, Y.; Chen, R.; Wang, Y.; Yang, Y. α-Pinene inhibits human prostate cancer growth in a mouse xenograft model. Chemotherapy, 2018, 63(1), 1-7.
[http://dx.doi.org/10.1159/000479863] [PMID: 29069647]
[7]
Chen, W.; Liu, Y.; Li, M.; Mao, J.; Zhang, L.; Huang, R.; Jin, X.; Ye, L. Anti-tumor effect of α-pinene on human hepatoma cell lines through inducing G2/M cell cycle arrest. J. Pharmacol. Sci., 2015, 127(3), 332-338.
[http://dx.doi.org/10.1016/j.jphs.2015.01.008] [PMID: 25837931]
[8]
Zhang, Z.; Guo, S.; Liu, X.; Gao, X. Synergistic antitumor effect of α-pinene and β-pinene with paclitaxel against non-small-cell lung carcinoma (NSCLC). Drug Res. (Stuttg.), 2015, 65(4), 214-218.
[PMID: 25188609]
[9]
Aydin, E.; Türkez, H.; Geyikoğlu, F. Antioxidative, anticancer and genotoxic properties of α-pinene on N2a neuroblastoma cells. Biologia, 2013, 68(5), 1004-1009.
[http://dx.doi.org/10.2478/s11756-013-0230-2]
[10]
da Silva, A.C.; Lopes, P.M.; de Azevedo, M.M.; Costa, D.C.; Alviano, C.S.; Alviano, D.S. Biological activities of α-pinene and β-pinene enantiomers. Molecules, 2012, 17(6), 6305-6316.
[http://dx.doi.org/10.3390/molecules17066305] [PMID: 23442885]
[11]
Wang, Y.; Gu, W.; Shan, Y.; Liu, F.; Xu, X.; Yang, Y.; Zhang, Q.; Zhang, Y.; Kuang, H.; Wang, Z.; Wang, S. Design, synthesis and anticancer activity of novel nopinone-based thiosemicarbazone derivatives. Bioorg. Med. Chem. Lett., 2017, 27(11), 2360-2363.
[http://dx.doi.org/10.1016/j.bmcl.2017.04.024] [PMID: 28431878]
[12]
Liao, S.; Shang, S.; Shen, M. Synthesis and anticancer activity of (+)-nopinone-based 2-amino-3-cyanopyridines. Front. Agr. Sci. Eng., 2015, 2(4), 335-340.
[http://dx.doi.org/10.15302/J-FASE-2015079]
[13]
Sharma, G.V.R.; Devi, B.; Reddy, K.S. Montmorillonite K10 catalyzed multi component reactions (MCR): Synthesis of novel thiazolidinones as anticancer agents. Heterocycl. Commun., 2015, 21(4), 187-190.
[http://dx.doi.org/10.1515/hc-2015-0035]
[14]
Ruddarraju, R.R.; Murugulla, A.C.; Kotla, R.; Tirumalasetty, M.C.B.; Wudayagiri, R.; Donthabakthuni, S.; Maroju, R. Design, synthesis, anticancer activity and docking studies of theophylline containing 1,2,3-triazoles with variant amide derivatives. MedChemComm, 2016, 8(1), 176-183.
[http://dx.doi.org/10.1039/C6MD00479B] [PMID: 30108703]
[15]
Choi, M.; Jo, H.; Kim, D.; Yun, J.; Kang, J.S.; Kim, Y.; Jung, J.K.; Hong, J.T.; Cho, J.; Kwak, J.H.; Lee, H. Design and synthesis of 2,3-dihydro- and 5-chloro-2,3-dihydro-naphtho-[1,2-b]furan-2-carboxylic acid N-(substitutedphenyl)amide analogs and their biological activities as inhibitors of NF-κB activity and anticancer agents. Arch. Pharm. Res., 2016, 39(5), 618-630.
[http://dx.doi.org/10.1007/s12272-016-0737-5] [PMID: 27021311]
[16]
Singh, S.; Ahmad, A.; Raghuvanshi, D.S.; Hasanain, M.; Agarwal, K.; Dubey, V.; Fatima, K.; Alam, S.; Sarkar, J.; Luqman, S.; Khan, F.; Tandon, S.; Gupta, A. Synthesis of 3,5-dihydroxy-7,8-dimethoxy-2-(4-methoxyphenyl)benzopyran-4-one derivatives as anticancer agents. Bioorg. Med. Chem. Lett., 2016, 26(21), 5322-5327.
[http://dx.doi.org/10.1016/j.bmcl.2016.09.036] [PMID: 27671497]
[17]
Thi, T A D.; Tuyet, N.T.K.; Nguyen, H.T. Synthesis and cytotoxic evaluation of novel amide-triazole-linked triterpenoid-AZT conjugates. Tetrahedron Lett., 2015, 56(1), 218-224.
[http://dx.doi.org/10.1016/j.tetlet.2014.11.069]
[18]
Jin, L.; Qu, H.E.; Huang, X.C.; Pan, Y.M.; Liang, D.; Chen, Z.F.; Wang, H.S.; Zhang, Y. Synthesis and biological evaluation of novel dehydroabietic acid derivatives conjugated with acyl-thiourea peptide moiety as antitumor agents. Int. J. Mol. Sci., 2015, 16(7), 14571-14593.
[http://dx.doi.org/10.3390/ijms160714571] [PMID: 26132564]
[19]
Ozgur, A.; Yenidunya, E.; Koca, I. Acyl thiourea derivatives containing pyrazole ring selective targeting of human aurora kinases in breast and bone cancer. Lett. Drug Des. Discov., 2015, 12(3), 180-189.
[http://dx.doi.org/10.2174/1570180811666141001005129]
[20]
Koca, İ.; Özgür, A.; Er, M.; Gümüş, M.; Açikalin Coşkun, K.; Tutar, Y. Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis. Eur. J. Med. Chem., 2016, 122, 280-290.
[http://dx.doi.org/10.1016/j.ejmech.2016.06.032] [PMID: 27376491]
[21]
Liao, S.; Shang, S.; Si, H. Synthesis and antibacterial activity study of carboxylic myrtanyl esters. Linchan Huaxue Yu Gongye, 2015, 35(6), 33-38.
[22]
Tojo, G.; Fernández, M. Oxidation of primary alcohols to carboxylic acids; Springer: New York, 2007.
[23]
Turan-Zitouni, G.; Altıntop, M.D.; Özdemir, A.; Kaplancıklı, Z.A.; Çiftçi, G.A.; Temel, H.E. Synthesis and evaluation of bis-thiazole derivatives as new anticancer agents. Eur. J. Med. Chem., 2016, 107, 288-294.
[http://dx.doi.org/10.1016/j.ejmech.2015.11.002] [PMID: 26599534]
[24]
Jain, S.; Pattnaik, S.; Pathak, K. Anticancer potential of thiazole derivatives: A retrospective review. Mini Rev. Med. Chem., 2017, 18(8), 640-655.
[PMID: 29173166]
[25]
Hamilton, M.A.; Russo, R.C.; Thurston, R.V. Trimmed Spearman-Karber method for estimating median lethal concentrations in toxicity bioassays. Environ. Sci. Technol., 1977, 11(7), 714-719.
[http://dx.doi.org/10.1021/es60130a004]
[26]
Palchaudhuri, R.; Hergenrother, P.J. DNA as a target for anticancer compounds: Methods to determine the mode of binding and the mechanism of action. Curr. Opin. Biotechnol., 2007, 18(6), 497-503.
[http://dx.doi.org/10.1016/j.copbio.2007.09.006] [PMID: 17988854]
[27]
Opalinska, J.B.; Gewirtz, A.M. Nucleic-acid therapeutics: Basic principles and recent applications. Nat. Rev. Drug Discov., 2002, 1(7), 503-514.
[http://dx.doi.org/10.1038/nrd837] [PMID: 12120257]
[28]
Jordan, M.A.; Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer, 2004, 4(4), 253-265.
[http://dx.doi.org/10.1038/nrc1317] [PMID: 15057285]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 3
Year: 2020
Page: [271 - 284]
Pages: 14
DOI: 10.2174/1570180816666181107094427

Article Metrics

PDF: 24
HTML: 3
EPUB: 1
PRC: 1